Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Perbedaan Harga & Kinerja Andalan Sakti Primaindo Tbk (ASPI) vs UBC Medical Indonesia Tbk. (LABS)

Andalan Sakti Primaindo Tbk
UBC Medical Indonesia Tbk.

Kinerja harga

Pergerakan harga dalam 24 jam terakhir

Statistik utama

Perbedaan Andalan Sakti Primaindo Tbk dan UBC Medical Indonesia Tbk.: Andalan Sakti Primaindo Tbk diperdagangkan di Rp535 (kapitalisasi pasar 340,91 M, volume 24 jam 1,84 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp146 (kapitalisasi pasar 584,6 M, volume 24 jam 1,44 jt). Perbedaan utamanya: UBC Medical Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar, dan Andalan Sakti Primaindo Tbk lebih aktif diperdagangkan (1,84 jt vs 1,44 jt). Mana yang lebih baik tergantung tujuan investasimu.

ASPILABS
Kapitalisasi Pasar
340,91 M584,6 M
Volume
1,84 jt1,44 jt
Lot
18,36 rb14,4 rb
Perputaran
934,18 jt209,72 jt
Harga Rata-rata
508,81145,64
Nilai Transaksi
934,18 jt209,72 jt
Harga Ekuilibrium Indikatif
535146
Volume Ekuilibrium Indikatif
348753

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

ASPI
Lihat detail
LABS
Lihat detail

Tentang Andalan Sakti Primaindo Tbk

PT. Andalan Sakti Primaindo Tbk. ("the Company") was established based on the Notarial Deed of Saniwati Suganda, S.H., No.81 dated 13 November 2012. Entiry parent is PT Andalan Sakti Inti.

Selengkapnya di halaman ASPI

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS